Point mutations at molecular gatekeeper positions of ABL confer STI571-but not 
PPI-resistance to Bcr-Abl-expressing cell lines.

Warmuth, M.; Simon, N.; Mathes, R.; Mitina, O.; Forster, K.; Moarefi, I.; Hallek, M.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Point mutations at molecular gatekeeper positions of ABL confer STI571-but not PPI-resistance to Bcr-Abl-expressing cell lines.

MPS-Authors

/persons/resource/persons78409

Moarefi, I.
Hartl, Franz-Ulrich / Cellular Biochemistry, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Warmuth, M., Simon, N., Mathes, R., Mitina, O., Forster, K., Moarefi, I., et al. (2001). Point mutations at molecular gatekeeper positions of ABL confer STI571-but not PPI-resistance to Bcr-Abl-expressing cell lines. Blood, 98(11), 3208.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-7106-5

Abstract

There is no abstract available